CClinicalTrials.gg
Sign In
Status unknownNCT05266755FLSSantPauUpdated Mar 18, 2022

Hospital Readmission After HIPr Fracture. Impact of a Territorial Fracture Liason Service

An interventional study of Fracture Territorial Liaison Service afert a Hip fracture in Hip Fractures, sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Status unknown at 1 site in Spain. Open to participants aged 65 Years to 99 Years. Per ClinicalTrials.gov, last updated 2022-03-18.

Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
65 Years to 99 Years
Sex
All
01

Study summary

The International Osteoporosis Foundation (IOF) and the American Society for Bone Research and Mineral Metabolism recommend the creation and implementation of fracture coordination services (FLS) as the most efficient way to address the problem. FLS has emerged as a new clinical approach that uses coordinated, multidisciplinary care to improve post-fracture outcomes and reduce recurrent fractures. It is a multidisciplinary and protocolized care model that must guarantee:

  1. Identify fragility fractures and people at risk for a fracture
  2. Fracture risk assessment
  3. Indication for treatment or referral
  4. Improvement in therapeutic compliance
  5. Reduce the risk of falls It is known that patients who have undergone a FLS model (vs no FLS), have lower mortality, lower risk of fracture, with a reduction of 35% and 56%, respectively, during two years of follow-up. One of the most important objectives of the FLS is the proper recognition and treatment of osteoporosis (OP) in patients with fragility fractures. A major problem is the lack of adherence to treatment for OP, and inclusion in an FLS program increases the prescription of bisphosphonates from 17.9% to 76%. In addition, a specific follow-up program means that 73% of patients followed by FLS continue to undergo anti-resorptive treatment after 2 years of having suffered a femur fracture.
Read the detailed description

Hypothesis After a femur fracture due to fragility, upon discharge from surgery at the Hospital de la Santa Creu i Sant Pau, including patients in a regional FLS program will make it possible to complete the study of the patient with fracture, improve adherence to treatment of OP (secondary prevention), and obtain better functional recovery.

02

Conditions studied

  • Hip Fractures
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 120 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is the lead sponsor of 335 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All hip fractures older than 65 years

Exclusion criteria

Exclusion Criteria:

  • Politraumatic fractures
  • Metastasic fractures
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Placebo comparator
    Patiens who will receive stanrdar care after hip fracture

    All the patients who will be on surgery after a hip fracture will receive after the hospital discharge the standar following we are doing now in our hospital

    Other: Fracture Territorial Liaison Service afert a Hip fracture

  • Active comparator
    Patiens who will receive FLS following after the hip fracture

    All the patients who will be on surgery after a hip fracture will receive after the hospital discharge a FLS following, multidisciplinary, with a web and mobile app aplication

    Other: Fracture Territorial Liaison Service afert a Hip fracture

Interventions

  • OtherFracture Territorial Liaison Service afert a Hip fracture

    Give a diferent than the current one way of follow up to the patients with hip fracture

06

What researchers measure

Primary outcomes

  1. Number of Deaths

    % of Number of deaths after 1st year o follow up

    Time frame: 1 year after discharge

  2. Number of Falls

    Number of Falls 1st year o follow up

    Time frame: 1 year after discharge

  3. Percentage of patients with adequated Osteoporotic treatment

    Percentage of patients with adequated osteoporotic treatment

    Time frame: 1 year after discharge

Secondary outcomes

  1. Barthel at the end of follow up

    Compare Barthel after hospital discharge with the end of follow up barthel. Minimum is 0 maximum is 100.

    Time frame: 1 year after discharge

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05266755
Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Responsible party
Sponsor
First posted
Mar 4, 2022
Start date
Mar 15, 2022 (estimated)
Primary completion
Jan 1, 2023 (estimated)
Completion
Apr 1, 2023 (estimated)
Last update
Mar 18, 2022

Study contacts

Jordi M Marcuello, Doctor
Contact
jmartinma@santpau.cat
629315207

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Fractures, Bone→

Other studies from this sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Start the discussion